24. TRG better evaluate pathological response and predict prognosis of gastric cancer patients following neoadjuvant chemotherapy
Objective: As preoperative chemotherapy for gastric cancer was
adopted widely, it is highly necessary to choose the criteria most
suitable for response evaluation. In this study we mainly compare
the efficacy of two response evaluation standards, so as to find
out the more reliable and reproducible one.
Methods (Materials): Tumor regression grade (TRG) and
grading based on percentage of residual tumor cells were
evaluated separately and respectively by two pathologists in 180
gastric cancer patients. Distribution, correlation and prognosis
value of two criteria was investigated.
Results: Patients with higher TRG grade also have more residual
tumor cells, but one grade can’t be converted to the other. TRG
had better Inter-observer agreement than the other (K=0.928 vs.
K=0.838). Both of them correlate well with 5 years overall survival,
but pTNM stage greatly affected prognosis value of the latter.
Combination of TRG and pTNM stage could predict survival
longer than 3 years with optimal sensitivity and specificity.
Conclusions: TRG and Residual tumor cell percentage grading
system can’t be integrated together despite much accordance between them. TRG system should be preferred according to
the result of our study. Combination of ypTNM stage and TRG
could predict the prognosis of gastric cancer patients following
induction chemotherapy more precisely.
Key words
Tumor regression grade; gastric cancer; neoadjuvant chemotherapy